Parallel — SEC Form D Filing

Parallel filed an SEC Form D on March 31, 2026, reporting $19.37M raised in Healthcare Technology.

Form D filing details

Filing
SEC Form D
Filing date
March 31, 2026
Amount reported
$19.37M
Round stage
Series A
Industry
Healthcare Technology
Website
https://www.beparallel.com/

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Hospitals struggle with inefficient medical coding processes that slow down workflows and reduce revenue.

Solution

Parallel provides AI agents that assist hospital teams with faster and more accurate medical coding, integrated into their existing systems.

Verdict

Investors said yes because they recognized the inefficiencies in medical coding as a significant pain point in healthcare operations, betting on the potential for AI to streamline these processes. This cleared because the narrative targeted a well-known problem in a heavily scrutinized industry, not because it presented a clear and compelling competitive advantage. The limited upside stems from the risk of new entrants and incumbents quickly adopting similar solutions, diluting potential market share.

Source: SEC EDGAR Form D filing